medical devices

Dr. Reddy’s Launches Semaglutide ‘Obeda’ in India Semaglutide injectables and vials on a lab bench with scientists and manufacturing equipment in the background.

sivam March 21, 2026

Dr. Reddy's Laboratories introduces Obeda, a semaglutide injectable, in India, enhancing their diabetes care portfolio. A new...

Dr. Reddy’s Launches Semaglutide ‘Obeda’ for Diabetes Medical professional with Obeda medication, syringe, and DNA helix in a sterile pharmaceutical manufacturing lab.

sivam March 21, 2026

Dr. Reddy's Laboratories introduces 'Obeda', a semaglutide version for diabetes management in India. Aims to expand its...

Dr. Reddy’s Launches Generic Semaglutide for Diabetes in India A scientist in a lab coat and blue gloves holding a semaglutide injection, with a holographic display of India and medical icons.

sivam March 21, 2026

Dr. Reddy's introduces Obeda, a generic semaglutide injection, the first DCGI-approved treatment for Type 2 diabetes in...

Helium Shortage: Indian Healthcare Faces Rising MRI Costs A patient undergoes an MRI scan, with blue energy representing helium flowing through the machine's intricate copper wiring.

sivam March 20, 2026

Helium supply disruptions in West Asia threaten MRI services in India, driving up costs for healthcare providers...

Mave Health Raises $2.1M for Mental Health Wearables Three smiling men, two seated and one standing, displaying a wearable headset and a tablet with a graph, with "Blume Ventures" text.

sivam March 19, 2026

Mave Health secures $2.1M seed funding led by Blume Ventures to launch innovative mental health wearable tech...

Agilent Acquires Biocare Medical for $950M: MedTech Deal Agilent's DNA logo merging with Biocare Medical's shield logo, symbolizing the acquisition.

sivam March 9, 2026

Agilent Technologies acquires Biocare Medical for $950M, a strategic move in the MedTech sector. This deal strengthens...

Cipla USA Recalls Nilotinib Anti-Cancer Drug Due to Defect A gloved hand holds a vial of Nilotinib, with a pharmaceutical manufacturing facility in the background.

sivam March 8, 2026

Cipla USA recalls Nilotinib anti-cancer capsules (150mg and 200mg) due to a manufacturing defect, as confirmed by...

Semaglutide vs. Tirzepatide: Novo Nordisk Gains in India A scientific image depicting Semaglutide, Novo Nordisk, Eli Lilly, and an upward arrow indicating market competition in India.

sivam March 8, 2026

Novo Nordisk's semaglutide is rapidly gaining ground in India's anti-obesity market, challenging Eli Lilly's tirzepatide. Discover how...

India to Lead Global Homoeopathy Market with Quality Certifications India map with glowing nodes, global map, pharmaceutical equipment, and quality certification logos (GMP, ISO 9001, AYUSH Premium).

sivam March 8, 2026

India is set to dominate the global homoeopathy market, driven by clinical expertise, strong practitioner networks, and...

Middle East Conflict Impacts Medical Tourism: India’s Shift Doctors in front of a hospital with a world map showing conflict zones and new market opportunities for medical devices.